Lyell Immunopharma, Inc. Earnings Per Share (Basic)
Lyell Immunopharma, Inc. (LYEL) reported Earnings Per Share (Basic) of -$1.92 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-06
- Lyell Immunopharma, Inc. earnings per share, basic for the quarter ending 2026-06-30 was -$1.92.
- Lyell Immunopharma, Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$1.10.
- Lyell Immunopharma, Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$2.13.
- Lyell Immunopharma, Inc. earnings per share, basic for the quarter ending 2025-06-30 was -$2.89.
- Lyell Immunopharma, Inc. earnings per share, basic for fiscal 2025 was -$16.06.
- Lyell Immunopharma, Inc. earnings per share, basic for fiscal 2024 was -$26.23.
- Lyell Immunopharma, Inc. earnings per share, basic for fiscal 2023 was -$18.70.
- Lyell Immunopharma, Inc. earnings per share, basic for fiscal 2022 was -$0.74.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$1.92 10-Q · filed 2026-08-06 | -$3.05 10-Q · filed 2026-08-06 | ||||||
| 2026-03-31 | -$1.10 10-Q · filed 2026-05-06 | |||||||
| 2025-12-31 | -$16.06 10-K · filed 2026-03-12 | |||||||
| 2025-09-30 | -$2.13 10-Q · filed 2025-11-12 | -$8.38 10-Q · filed 2025-11-12 | ||||||
| 2025-06-30 | -$2.89 10-Q · filed 2026-08-06 | -$6.42 10-Q · filed 2026-08-06 | ||||||
| 2025-03-31 | -$3.54 10-Q · filed 2026-05-06 | -$0.18 10-Q · filed 2025-05-13 | ||||||
| 2024-12-31 | -$26.23 10-K · filed 2026-03-12 | -$1.31 10-K · filed 2025-03-11 | ||||||
| 2024-09-30 | -$3.48 10-Q · filed 2025-11-12 | -$0.17 10-Q · filed 2024-11-07 | -$11.83 10-Q · filed 2025-11-12 | -$0.59 10-Q · filed 2024-11-07 | ||||
| 2024-06-30 | -$3.59 10-Q · filed 2025-08-12 | -$0.18 10-Q · filed 2024-08-07 | -$8.36 10-Q · filed 2025-08-12 | -$0.42 10-Q · filed 2024-08-07 | ||||
| 2024-03-31 | -$0.24 10-Q · filed 2025-05-13 | |||||||
| 2023-12-31 | -$18.70 10-K · filed 2026-03-12 | -$0.93 10-K · filed 2024-02-28 | ||||||
| 2023-09-30 | -$0.20 10-Q · filed 2024-11-07 | -$0.73 10-Q · filed 2024-11-07 | ||||||
| 2023-06-30 | -$0.26 10-Q · filed 2024-08-07 | -$0.52 10-Q · filed 2024-08-07 | ||||||
| 2023-03-31 | -$0.27 10-Q · filed 2024-05-06 | |||||||
| 2022-12-31 | -$0.74 10-K · filed 2025-03-11 | |||||||
| 2022-09-30 | -$0.28 10-Q · filed 2023-11-07 | -$0.71 10-Q · filed 2023-11-07 | ||||||
| 2022-06-30 | -$0.15 10-Q · filed 2023-08-08 | -$0.43 10-Q · filed 2023-08-08 | ||||||
| 2022-03-31 | -$0.28 10-Q · filed 2023-05-04 | |||||||
| 2021-12-31 | -$0.35 derived: net income ÷ weighted average shares · filed 2024-02-28 | -$0.55 derived: net income ÷ weighted average shares · filed 2024-02-28 | -$1.12 derived: net income ÷ weighted average shares · filed 2024-02-28 | -$1.84 10-K · filed 2024-02-28 | ||||
| 2021-09-30 | -$0.20 10-Q · filed 2022-11-08 | -$0.79 derived: net income ÷ weighted average shares · filed 2022-11-08 | -$1.66 10-Q · filed 2022-11-08 | |||||
| 2021-06-30 | -$1.47 10-Q · filed 2022-08-04 | -$3.91 10-Q · filed 2022-08-04 | ||||||
| 2021-03-31 | -$3.19 10-Q · filed 2022-05-10 | |||||||
| 2020-12-31 | -$15.69 10-K · filed 2023-02-28 | |||||||
| 2019-12-31 | -$24.04 10-K · filed 2022-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |